Indefinite Delivery Contract HHSD200201035150I
Award Date
7/1/10
Last Date to Order
6/30/11
Federal Agency
CDC Office of Acquisition Services
Awardee
Merck Sharp & Dohme Corp.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention (CDC) has awarded a multiple-award Indefinite Delivery Contract (IDC) valued up to $69,520,654.32 to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of various adult vaccines. The contract has a period of performance from July 1, 2024 to June 30, 2025 and does not involve any set-aside designations. The IDC requires Merck, as a pharmaceutical manufacturer, to provide a wide range of adult vaccines including Hepatitis A,...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract, valued at a ceiling of $66,688,290, is for the procurement of adult vaccines under the VACCINES major program code. The contract has a period of performance from July 1, 2025 to June 30, 2026. As an established federal contractor, Merck holds several significant IDVs with the CDC,...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Merck Sharp & Dohme LLC for adult vaccines. The contracts have a potential value of $83,485,760 and a period of performance from July 1, 2021 to June 30, 2022. Merck will provide 13 standard adult vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, measles/mumps/rubella, meningococcal conjugate, human papillomavirus, and...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Glaxosmithkline Holdings (Americas) Inc. as the prime contractor. The contract has a ceiling value of $261,469,025.27 and a period of performance ending on June 30, 2011. The purpose of this IDC is to provide adult vaccines, as part of the CDC's Adult Vaccine Contract 2010 - 2011 program. The contract was not set aside for any specific business category. It was...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under a competitive solicitation to purchase standard adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $85.6 million. Merck Sharp & Dohme LLC was awarded one of these contracts as the prime contractor. The contracts enable the CDC to order 12 types of adult vaccines for delivery within 15 business days....
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp., a subsidiary of Schering Plough Corporation, to provide vaccine-related services. The single-award contract has a ceiling value of $56,988,922.50 and a period of performance through February 28, 2011. The contract was not set aside and aims to procure vaccine storage and rotation services. This delivery order contract is one of...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the purchase of 20 standard pediatric vaccines. The contract supports the CDC's Vaccines for Children program and adult vaccination initiatives under Section 317(j) of the Public Health Service Act. This multiple award IDC has a total ceiling value of $2,565,312,500 and a period of performance of 12 months from the award date...
This indefinite delivery contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Centers for Disease Control and Prevention (CDC) Pittsburgh to procure a variety of pharmaceutical drugs and vaccines. The $5,863,720.17 contract has a period of performance from September 16, 2016 to September 15, 2021. Merck, a major pharmaceutical manufacturer, is providing the CDC with multiple vaccine types for both adult and pediatric populations under this IDV. This includes...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp., a subsidiary of Schering Plough Corporation. The contract has a ceiling value of $1,465,459,641.64 and a period of performance from July 1, 2009 to June 30, 2010. The IDC is focused on providing VFA 2009, which likely refers to vaccine-related products and services. Merck Sharp & Dohme Corp. has been awarded multiple...
This Indefinite Delivery Contract (IDC) award from the Centers for Disease Control and Prevention (CDC) is for the procurement of 12 standard adult vaccines to support state health department immunization programs. The $62,183,800 multiple-award contract has a period of performance from July 1, 2022 to June 30, 2023. The prime contractor is Pfizer Inc., a large pharmaceutical manufacturer that serves as a major federal supplier of medical products and vaccines. The contract requires the delivery...